Balyasny Asset Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Balyasny Asset Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-187,500	Closed	-$15.9K	–	3163
2023 Q1	$15.9K	Hold	187,500	–	–	﹤0.01%	2465
2022 Q4	$956	Hold	187,500	–	–	﹤0.01%	2702
2022 Q3	$23K	Hold	187,500	–	–	﹤0.01%	2573
2022 Q2	$20K	Hold	187,500	–	–	﹤0.01%	2489
2022 Q1	$60K	Hold	187,500	–	–	﹤0.01%	2211
2021 Q4	$107K	Buy	+187,500	New	+$96.2K	﹤0.01%	1951

Balyasny Asset Management's LVACW Position: Q2 2023 in Review

Balyasny Asset Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 187,500 shares — an estimated $15.9K sold.

Balyasny Asset Management first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $107K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Balyasny Asset Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 187,500 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $15.9K.
Balyasny Asset Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
Balyasny Asset Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $107K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.